A4 – Trial Management Considerations for Investigator Initiated Studies

This session will explore the trial management of investigator initiated studies from the following perspectives  (1) The modernisation of investigator-Initiated clinical trials (2) Managing investigator initiated studies in the Asia-Pacific region and beyond (3) Clinical trial supplies for investigator initiated studies including relabelling, repackaging, sourcing clinical trials supplies and logistics.

Chairperson: Peta-Anne Paul-Brent, Australian Kidney Trial Network (and member of the congress committee)